The assay of antithrombin using a synthetic chromogenic substrate for thrombin

Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomography.

Scandinavian journal of rheumatology·2017

Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion.

Journal of thrombosis and haemostasis : JTH·2003

The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.

Journal of thrombosis and haemostasis : JTH·2003

Nicotinamide is a potent inhibitor of proinflammatory cytokines.

Clinical and experimental immunology·2003

Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.

Haemophilia : the official journal of the World Federation of Hemophilia·2002

Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?

Thrombosis and haemostasis·2002

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Thrombosis research·2026

Development and external validation of a text-matching algorithm to identify patients with lower extremity deep venous thrombosis from radiology reports at five medical centers.

Thrombosis research·2026

Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country.

Thrombosis research·2026

Long-term analytical performance of apixaban measurements based on external quality assessment data.

Thrombosis research·2026

Safety and efficacy of fondaparinux in pediatric venous thromboembolism: A retrospective cohort study.

Thrombosis research·2026

Phenotypic and glycosylation profiles of the FGG c.902G > A (p.Arg301His) mutation in a Chinese pedigree with congenital dysfibrinogenemia.

Thrombosis research·2026

Finger-actuated microfluidic device for point-of-care circulating cell-free nucleic acid extraction.

Lab on a chip·2026

Extending Quality Control Procedures for Multiplexed Clinical Assays.

Clinical chemistry·2026

Characteristics of Severe and Typical Agranulocytosis Induced by Antithyroid Drugs.

Clinical pharmacology and therapeutics·2026

Severe Alcohol-Associated Lactic Acidosis Presenting With Extreme Hyperlactataemia: A Case Report.

Cureus·2026

STINGing the brain: S-nitrosylation drives neuroinflammation in Alzheimer's disease.

Cell chemical biology·2026

Sigma metric and Quality Goal Index assessment of hemoglobin A1c analytical performance in an ambulatory accredited laboratory.

Laboratory medicine·2026

Related Experiment Videos

The assay of antithrombin using a synthetic chromogenic substrate for thrombin

Related Concept Videos

Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomography.

Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion.

The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.

Nicotinamide is a potent inhibitor of proinflammatory cytokines.

Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.

Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Development and external validation of a text-matching algorithm to identify patients with lower extremity deep venous thrombosis from radiology reports at five medical centers.

Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country.

Long-term analytical performance of apixaban measurements based on external quality assessment data.

Safety and efficacy of fondaparinux in pediatric venous thromboembolism: A retrospective cohort study.

Phenotypic and glycosylation profiles of the FGG c.902G > A (p.Arg301His) mutation in a Chinese pedigree with congenital dysfibrinogenemia.

Finger-actuated microfluidic device for point-of-care circulating cell-free nucleic acid extraction.

Extending Quality Control Procedures for Multiplexed Clinical Assays.

Characteristics of Severe and Typical Agranulocytosis Induced by Antithyroid Drugs.

Severe Alcohol-Associated Lactic Acidosis Presenting With Extreme Hyperlactataemia: A Case Report.

STINGing the brain: S-nitrosylation drives neuroinflammation in Alzheimer's disease.

Sigma metric and Quality Goal Index assessment of hemoglobin A1c analytical performance in an ambulatory accredited laboratory.

Related Experiment Videos

The assay of antithrombin using a synthetic chromogenic substrate for thrombin

Related Concept Videos

Related Articles